ArticleCancer science2025

Discovery of Novel RASGRF2 Fusions as a Therapeutic Target in Lung Adenocarcinoma of Never or Light Smokers.

Yuki Terashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.